Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci
Open Access
- 1 January 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (1) , 92-98
- https://doi.org/10.1128/aac.35.1.92
Abstract
Activities of combinations of beta-lactams, daptomycin, gentamicin, teicoplanin, and vancomycin against 11 clinical isolates of Enterococcus faecium highly resistant to glycopeptides, three plasmid-cured derivatives, eight E. faecalis and E. faecium transconjugants, and two susceptible recipient strains were tested. A marked synergy between penicillins or imipenem and glycopeptides against the glycopeptide-resistant strains but not against the glycopeptide-susceptible strains was observed by the double-disk agar diffusion assay. The synergy of combinations of amoxicillin, imipenem, penicillin G, or piperacillin with vancomycin or teicoplanin against resistant strains was confirmed by the checkerboard technique. The fractional inhibitory concentration indexes were generally below 0.25, except for one strain of E. faecium resistant to high levels of penicillin G. However, the combinations were not bactericidal as tested by time-killing experiments, and high concentrations (64 micrograms/ml) of amoxicillin, penicillin G, or piperacillin combined with 8 micrograms of vancomycin or teicoplanin per ml tended to be antagonistic. Addition of 4 micrograms of gentamicin per ml to these combinations enhanced their bactericidal effect, but they occasionally remained slightly less effective than beta-lactams associated with gentamicin. The combination of 10 micrograms of daptomycin per ml with gentamicin was bactericidal after 6 h against 11 glycopeptide-resistant strains.Keywords
This publication has 17 references indexed in Scilit:
- Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1990
- Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256Antimicrobial Agents and Chemotherapy, 1990
- High-level vancomycin-resistant enterococci causing hospital infectionsEpidemiology and Infection, 1989
- Inducible Resistance to Vancomycin in Enterococcus faecium D366The Journal of Infectious Diseases, 1989
- Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256Antimicrobial Agents and Chemotherapy, 1989
- Transferable vancomycin and teicoplanin resistance in Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1989
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococciJournal of Antimicrobial Chemotherapy, 1987
- The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin againstStreptococcus faecalisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Species-Specific Resistance to Antimicrobial Synergism in Streptococcus faecium and Streptococcus faecalisThe Journal of Infectious Diseases, 1979